# IOVANCE BIOTHERAPEUTICS INC (IOVA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/IOVA/

- Reporting holders: 5
- Reported value: $16.6M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Mirador Capital Partners LP](https://holderbook.com/funds/1633446-mirador-capital-partners-lp/) | $16.2M | 1,095,740 | 1.9% | 5 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $133.2K | 8,987 | 0.0% | 4 |
| [GK Wealth Management LLC](https://holderbook.com/funds/2069222-gk-wealth-management-llc/) | $106.7K | 7,196 | 0.1% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $84.4K | 5,694 | 0.0% | 15 |
| [Wealth Enhancement Trust Services, Inc.](https://holderbook.com/funds/2067696-wealth-enhancement-trust-services-inc/) | $59.3K | 4,000 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $16.6M |
| Q2 2026 | 293 | $1.4B |
| Q1 2026 | 285 | $981.4M |
| Q4 2025 | 260 | $735.0M |
| Q3 2025 | 251 | $476.9M |
| Q2 2025 | 251 | $389.5M |
| Q1 2025 | 298 | $814.9M |
| Q4 2024 | 303 | $1.9B |
| Q3 2024 | 287 | $2.3B |
| Q2 2024 | 298 | $1.9B |
| Q1 2024 | 283 | $3.5B |
| Q4 2023 | 241 | $1.8B |